Data for: Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/zrjwzwz65t
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Data for Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
